Anthony Amato - Sep 11, 2024 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role: Chief Executive Officer, Director
Signature: /s/ Anthony Amato
Stock symbol: BSGM
Transactions as of: Sep 11, 2024
Transactions value $: $0
Form type: 4
Date filed: 9/13/2024, 04:05 PM
Previous filing: Jul 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSGM	Common Stock	Award	$0	+275K	+49.27%	$0.00	833K	Sep 11, 2024	Direct	F1
transaction	BSGM	Common Stock	Award	$0	+1.28M	+153.02%	$0.00	2.11M	Sep 11, 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSGM	Option (right to buy)	Award		+2.4M			2.4M	Sep 11, 2024	Common Stock	2.4M	$0.45	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of restricted stock were granted and fully vested as of September 11, 2024 (the "Date of Grant"), based on a closing price of $0.4479 per share on such date.
F2	The shares of restricted stock vest biannually over three years in equal installments with vesting commencing on the Date of Grant, based on the closing price of $.04479 per share on such date.
F3	The option to purchase shares of the Issuers common stock (the "Option") has an exercise price of $0.4479 per share. 1,200,000 of the Option vested and became exercisable on the Date of Grant and the remaining 1,200,000 unvested Option will vest bi-annually over the term of 3 years commencing on the Date of Grant, subject to continued service with the Company through each relevant vesting date.